|
⚲
|
| Keyboard |
| Zachary Jennifer
✚
|
|
|---|---|
| CIK # | 0001737231 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001737231] | |
| 4 | [0001737231] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Zachary Jennifer | |
| RegenxBio Inc | |
| Merck & Co Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Merck & Co Inc MRK
Stock Option (Right to Buy) · derivative
|
2026-02-09 | Option exercise | 38,835 | $0.00 | |
|
Merck & Co Inc MRK
Common Stock
|
2026-02-09 | Option exercise | 38,835 | $119.15 | 4,627,190 |
|
Merck & Co Inc MRK
Common Stock
|
2026-02-09 | Sell | 38,835 | $119.15 | 4,627,190 |
|
Merck & Co Inc MRK
Common Stock
|
2026-02-09 | Sell | 56,792 | $119.15 | 6,766,767 |
|
Merck & Co Inc MRK
Common Stock
|
2026-02-09 | Option exercise | 25,946 | $119.15 | 3,091,466 |
|
Merck & Co Inc MRK
Common Stock
|
2026-02-09 | Option exercise | 56,792 | $119.15 | 6,766,767 |
|
Merck & Co Inc MRK
Common Stock
|
2026-02-09 | Sell | 25,946 | $119.15 | 3,091,466 |
|
Merck & Co Inc MRK
Stock Option (Right to Buy) · derivative
|
2026-02-09 | Option exercise | 25,946 | $0.00 | |
|
Merck & Co Inc MRK
Stock Option (Right to Buy) · derivative
|
2026-02-09 | Option exercise | 56,792 | $0.00 | |
|
Merck & Co Inc MRK
Common Stock
|
2026-01-26 | Grant | 11,583 | $107.40 | 1,244,014 |
|
RegenxBio Inc RGNX
Stock Options (Right to Buy) · derivative
|
2025-05-30 | Grant | 39,815 | $0.00 | |
|
RegenxBio Inc RGNX
Common Stock
|
2025-05-30 | Grant | 7,768 | $0.00 | |
|
Merck & Co Inc MRK
Stock Option (Right to Buy) · derivative
|
2025-04-29 | Grant | 40,301 | $0.00 | |
|
Merck & Co Inc MRK
Restricted Stock Unit · derivative
|
2025-04-29 | Grant | 8,854 | $0.00 | |
|
Merck & Co Inc MRK
Common Stock
|
2025-01-27 | Grant | 25,423 | $97.94 | 2,489,929 |
|
RegenxBio Inc RGNX
Stock Options (Right to Buy) · derivative
|
2024-05-31 | Grant | 24,454 | $0.00 | |
|
RegenxBio Inc RGNX
Common Stock
|
2024-05-31 | Grant | 4,790 | $0.00 | |
|
Merck & Co Inc MRK
Stock Option (Right to Buy) · derivative
|
2024-04-30 | Grant | 35,156 | $0.00 | |
|
Merck & Co Inc MRK
Stock Option (Right to Buy) · derivative
|
2024-02-02 | Option exercise | 19,417 | $0.00 | |
|
Merck & Co Inc MRK
Common Stock
|
2024-02-02 | Sell | 49,499 | $126.97 | 6,284,888 |
| showing 20 of 57 most recent transactions | |||||